Nabilone for Agitation in Frontotemporal Dementia

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

Canada

University of British Columbia, St Paul's Hospital, Vancouver, British Columbia

Brain and Mind Institute, University of Western Ontario, London, Ontario

Sunnybrook Health Sciences Centre, Toronto, Ontario

Baycrest Hospital, University of Toronto, Toronto, Ontario

Western Hospital - University of Toronto, Toronto, Ontario

CHU de Québec, Université Laval, Laval, Quebec

The Douglas Research Centre, Montreal, Quebec